This inventor holds 3 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignees: Medicosbiotech, Inc., Korea Advanced Institute of Science and Technology. Active years: 2019-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2019-2026
Title: The Innovative Contributions of Inventor Hannah Chung
Introduction
Hannah Chung, an accomplished inventor based in Daejeon, South Korea, has made significant strides in the field of biotechnology. With one patent to her name, she is dedicated to advancing the production of recombinant proteins, which are crucial for various medical and industrial applications.
Latest Patents
Hannah Chung’s notable patent is titled "Method for preparing recombinant proteins through reduction of rnpA gene expression." This innovative method enhances the production of challenging-to-express recombinant proteins in microorganisms. By utilizing a recombinant microorganism that incorporates a gene encoding the target protein alongside an sRNA targeting the rnpA gene, the expression levels of large and useful proteins can be significantly increased. This advancement not only benefits research but also holds promise for future therapeutic applications.
Career Highlights
As an inventor at MedicosBiotech, Inc., Hannah Chung has established herself as a valuable asset in the biotech industry. Her focus on improving recombinant protein production showcases her commitment to addressing complex scientific challenges. Her work at MedicosBiotech exemplifies the potential for innovation within the medical biotechnology sector.
Collaborations
Throughout her career, Hannah has collaborated with esteemed colleagues, including Sang Yup Lee. These partnerships enrich her research and development efforts, facilitating advancements in the field of biotechnology. Together, they contribute to MedicosBiotech's mission of pioneering innovative solutions for protein expression challenges.
Conclusion
Hannah Chung’s innovative spirit and dedication to biotechnology mark her as a remarkable inventor in her field. Her patent has the potential to significantly enhance recombinant protein production, paving the way for breakthroughs in medical research and therapy. As she continues her work at MedicosBiotech, the scientific community eagerly anticipates her future contributions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile